Default Fellow

Mark Schankerman

Filter By:


Recent Commentary

Patents and Cumulative Innovation: Causal Evidence from the Courts

by Alberto Galasso, Mark Schankermanvia IP2 Working Paper Series
Thursday, January 15, 2015

IP² Working Paper No. 15005 - Cumulative innovation is central to economic growth. Do patent rights facilitate or impede follow-on innovation?

Patents and the Global Diffusion of New Drugs

by Iain Cockburn, Jean O. Lanjouw, Mark Schankermanvia IP2 Working Paper Series
Monday, September 29, 2014

IP² Working Paper No. 14013 - This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002 and information on the duration and content of patent and price control regimes.